Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima Jeha

Showing results (61-70 of 223) with videos related to

Pageof 23
Sort By:
JCO Global Oncology|January 23, 2026
Highlights From the 2025 Pediatric Oncology East and Mediterranean Biennial Conference: Advancing Pediatric Oncology Across the Eastern MediterraneanRawad Rihani, Sima Jeha, Luham Abu Rashida, et al.
Blood Cancer Journal|July 26, 2020
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access studyFranco Locatelli, Gerhard Zugmaier, Noemi Mergen, et al.
Blood Cancer Journal|February 10, 2021
Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access studyFranco Locatelli, Gerhard Zugmaier, Noemi Mergen, et al.
JCO Global Oncology|February 13, 2023
Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean RegionRaya Saab, Victor Santana, Anas Obeid, et al.
Pediatric Blood & Cancer|October 28, 2020
Ultrasound has limited diagnostic utility in children with acute lymphoblastic leukemia developing pancreatitisRebecca Richardson, Cara E Morin, Charles A Wheeler, et al.
Implementation Science Communications|June 11, 2022
Evaluating blinatumomab implementation in low- and middle-income countries: a study protocolCaitlyn Duffy, Victor Santana, Hiroto Inaba, et al.
Blood Cancer Journal|October 28, 2021
Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access studyFranco Locatelli, Gerhard Zugmaier, Noemi Mergen, et al.
Pediatric Blood & Cancer|July 4, 2020
Prospective randomized trial of interventions for vincristine-related neuropathic painDoralina L Anghelescu, Jessica Michala Tesney, Sima Jeha, et al.
Haematologica|August 18, 2025
Asparaginase-associated pancreatitis during therapy for pediatric acute lymphoblastic leukemiaM Beth McCarville, Emily Ashcraft, Raul C Ribeiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic LeukemiaJoshua Wolf, Li Tang, Patricia M Flynn, et al.
Pageof 23

Showing results (61-70 of 223) with videos related to

Sort By:
Pageof 23
JCO Global Oncology|January 23, 2026
Highlights From the 2025 Pediatric Oncology East and Mediterranean Biennial Conference: Advancing Pediatric Oncology Across the Eastern MediterraneanRawad Rihani, Sima Jeha, Luham Abu Rashida, et al.
Blood Cancer Journal|July 26, 2020
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access studyFranco Locatelli, Gerhard Zugmaier, Noemi Mergen, et al.
Blood Cancer Journal|February 10, 2021
Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access studyFranco Locatelli, Gerhard Zugmaier, Noemi Mergen, et al.
JCO Global Oncology|February 13, 2023
Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean RegionRaya Saab, Victor Santana, Anas Obeid, et al.
Pediatric Blood & Cancer|October 28, 2020
Ultrasound has limited diagnostic utility in children with acute lymphoblastic leukemia developing pancreatitisRebecca Richardson, Cara E Morin, Charles A Wheeler, et al.
Implementation Science Communications|June 11, 2022
Evaluating blinatumomab implementation in low- and middle-income countries: a study protocolCaitlyn Duffy, Victor Santana, Hiroto Inaba, et al.
Blood Cancer Journal|October 28, 2021
Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access studyFranco Locatelli, Gerhard Zugmaier, Noemi Mergen, et al.
Pediatric Blood & Cancer|July 4, 2020
Prospective randomized trial of interventions for vincristine-related neuropathic painDoralina L Anghelescu, Jessica Michala Tesney, Sima Jeha, et al.
Haematologica|August 18, 2025
Asparaginase-associated pancreatitis during therapy for pediatric acute lymphoblastic leukemiaM Beth McCarville, Emily Ashcraft, Raul C Ribeiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic LeukemiaJoshua Wolf, Li Tang, Patricia M Flynn, et al.
Pageof 23